Optimized CLARITY technique detects reduced parvalbumin density in a genetic model of schizophrenia

BACKGROUND Novel tissue clearing technologies have, for the first time, made it possible to study intact tissue samples. This approach provides a tool for further clarifying findings from animal models of schizophrenia by studying parvalbumin-positive (PV+) interneuron density from a 3D perspective. NEW METHOD This study has developed an optimised CLARITY protocol, including an improved electrophoretic tissue clearing (ETC) chamber, an evaluation of antibody diffusion into cleared tissue slices, and a computational method for detecting PV+ interneurons in 3D. RESULTS A reduced PV+ interneuron density was found in both prelimbic and motor cortex regions of the Df(h15q13)/+ mice, while no changes were observed in the Df(h22q11)/+ mice. COMPARISON WITH EXISTING METHOD The developed ETC chamber enables tissue clearing of variable tissue sizes while minimizing the resistance. It was found that a high concentration of primary and secondary antibodies were necessary for sufficient antibody staining of PV+ interneurons. Additionally, the developed computational method showed improved detection rates of interneurons compared to non-processed image stacks. CONCLUSION Our optimization of the CLARITY technology and automated 3D counting of cells were found to be useful for quantification of PV+ interneuron density. The results may provide insight into understanding the pathophysiology underlying the phenotype observed in Df(h15q13)/+ mice.

[1]  K. Deisseroth,et al.  Parvalbumin neurons and gamma rhythms enhance cortical circuit performance , 2009, Nature.

[2]  J. Gordon,et al.  Developmental Inhibition of Gsk3 Rescues Behavioral and Neurophysiological Deficits in a Mouse Model of Schizophrenia Predisposition , 2016, Neuron.

[3]  C. Beasley,et al.  GABAergic neuronal subtypes in the human frontal cortex — development and deficits in schizophrenia , 2001, Journal of Chemical Neuroanatomy.

[4]  Karl Herrup,et al.  Individual Cytokines Modulate the Neurological Symptoms of ATM Deficiency in a Region Specific Manner,, , 2015, eNeuro.

[5]  A. LaMantia,et al.  Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS. , 2015, Cerebral cortex.

[6]  J. Whittaker An analysis of melanogenesis in differentiating pigment cells of ascidian embryos. , 1966, Developmental biology.

[7]  Jack R Glaser,et al.  Current automated 3D cell detection methods are not a suitable replacement for manual stereologic cell counting , 2014, Front. Neuroanat..

[8]  Yu Jin Jang,et al.  ACT-PRESTO: Rapid and consistent tissue clearing and labeling method for 3-dimensional (3D) imaging , 2016, Scientific Reports.

[9]  G. Reynolds,et al.  Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat , 2006, Journal of psychopharmacology.

[10]  Rajan P Kulkarni,et al.  Single-Cell Phenotyping within Transparent Intact Tissue through Whole-Body Clearing , 2014, Cell.

[11]  L. Rinaman,et al.  Simplified CLARITY for visualizing immunofluorescence labeling in the developing rat brain , 2016, Brain Structure and Function.

[12]  Bin Xu,et al.  The 22q11.2 microdeletion: Fifteen years of insights into the genetic and neural complexity of psychiatric disorders , 2011, International Journal of Developmental Neuroscience.

[13]  C. Beasley,et al.  Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins , 2002, Biological Psychiatry.

[14]  Aaron S. Andalman,et al.  Structural and molecular interrogation of intact biological systems , 2013, Nature.

[15]  Paul Pavlidis,et al.  Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model , 2008, Nature Genetics.

[16]  G. Reynolds,et al.  Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat , 2010, Behavioural Brain Research.

[17]  Helge B. D. Sørensen,et al.  A Mouse Model that Recapitulates Cardinal Features of the 15q13.3 Microdeletion Syndrome Including Schizophrenia- and Epilepsy-Related Alterations , 2014, Biological Psychiatry.

[18]  Hans-Christian Hege,et al.  Generation of dense statistical connectomes from sparse morphological data , 2014, Front. Neuroanat..

[19]  Joseph A. Gogos,et al.  Age-Dependent Specific Changes in Area CA2 of the Hippocampus and Social Memory Deficit in a Mouse Model of the 22q11.2 Deletion Syndrome , 2016, Neuron.

[20]  Brianne A. Kent,et al.  A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment , 2016, Psychopharmacology.

[21]  Anthony-Samuel LaMantia,et al.  Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome , 2009, Proceedings of the National Academy of Sciences.

[22]  A. LaMantia,et al.  Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome , 2012, Proceedings of the National Academy of Sciences.

[23]  J. Gordon,et al.  Impaired hippocampal–prefrontal synchrony in a genetic mouse model of schizophrenia , 2010, Nature.

[24]  Incheol Seo,et al.  Improved application of the electrophoretic tissue clearing technology, CLARITY, to intact solid organs including brain, pancreas, liver, kidney, lung, and intestine , 2014, BMC Developmental Biology.

[25]  Kenneth M. Johnson,et al.  Postnatal Phencyclidine Administration Selectively Reduces Adult Cortical Parvalbumin-Containing Interneurons , 2008, Neuropsychopharmacology.

[26]  Paul W. Frankland,et al.  Optimization of CLARITY for Clearing Whole-Brain and Other Intact Organs1,2,3 , 2015, eNeuro.